Cefuroxime pharmacokinetics in pediatric cardiovascular surgery patients undergoing cardiopulmonary bypass

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 25, Issue 3, 2011, Pages 425-430

  Knoderer, Chad A ^a,b,c   Saft, Sarah A ^b   Walker, Scott G ^c   Rodefeld, Mark D ^c   Turrentine, Mark W ^c   Brown, John W ^c   Healy, Daniel P ^d   Sowinski, Kevin M ^c,e  

^a BUTLER UNIVERSITY   (United States)

^b RILEY HOSPITAL FOR CHILDREN   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CINCINNATI   (United States)

^e PURDUE UNIVERSITY   (United States)

Author keywords

cardiopulmonary bypass; cefuroxime; chromatography; liquid; pediatric; pharmacokinetics

Indexed keywords

CARBON DIOXIDE; CEFUROXIME;

ABSENCE OF SIDE EFFECTS; ARTICLE; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; CARDIOVASCULAR SURGERY; CHILD; CLINICAL ARTICLE; DRUG CLEARANCE; DRUG HALF LIFE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFANT; MALE; MAXIMUM PLASMA CONCENTRATION; PEDIATRIC SURGERY; PLASMA CONCENTRATION-TIME CURVE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SINGLE DRUG DOSE; STEADY STATE;

CARDIOPULMONARY BYPASS; CARDIOVASCULAR SURGICAL PROCEDURES; CEFUROXIME; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; PROSPECTIVE STUDIES;

EID: 79957690994     PISSN: 10530770     EISSN: 15328422     Source Type: Journal    
DOI: 10.1053/j.jvca.2010.07.022     Document Type: Article

References (35)

1. Bratzler DW, Houck PM: Antimicrobial prophylaxis for surgery: An advisory statement from the National Surgical Infection Prevention Project. Am J Surg 189:395-404, 2005 (Pubitemid 40488232)
2. Mehta PA, Cunningham CK, Colella CB, et al: Risk factors for sternal wound and other infections in pediatric cardiac surgery patients. Pediatr Infect Dis J 19:1000-1004, 2000
3. Combes A, Trouillet JL, Baudot J, et al: Is it possible to cure mediastinitis in patients with major postcardiac surgery complications? Ann Thorac Surg 72:1592-1597, 2001
4. Edwards MS, Baker CJ: Median sternotomy wound infections in children. Pediatr Infect Dis 2:105-109, 1983 (Pubitemid 13098160)
5. Long CB, Shah SS, Lautenbach E, et al: Postoperative mediastinitis in children: Epidemiology, microbiology and risk factors for Gram-negative pathogens. Pediatr Infect Dis J 24:315-319, 2005 (Pubitemid 40525338)
6. Tabbutt S, Duncan BW, McLaughlin D, et al: Delayed sternal closure after cardiac operations in a pediatric population. J Thorac Cardiovasc Surg 113:886-893, 1997 (Pubitemid 27216497)
7. Erez E, Katz M, Sharoni E, et al: Pectoralis major muscle flap for deep sternal wound infection in neonates. Ann Thorac Surg 69:572-577, 2000 (Pubitemid 30125595)
8. Desmond J, Lovering A, Harle C, et al: Topical vancomycin applied on closure of the sternotomy wound does not prevent high levels of systemic vancomycin. Eur J Cardiothorac Surg 23:765-770, 2003 (Pubitemid 36566571)
9. Levi N, Olsen PS: Primary closure of deep sternal wound infection following open heart surgery: A safe operation? J Cardiovasc Surg (Torino) 41:241-245, 2000 (Pubitemid 30386525)
10. Tortoriello TA, Friedman JD, McKenzie ED, et al: Mediastinitis after pediatric cardiac surgery: A 15-year experience at a single institution. Ann Thorac Surg 76:1655-1660, 2003 (Pubitemid 37378330)
11. Engelman R, Shahian D, Shemin R, et al: The Society of Thoracic Surgeons practice guideline series: Antibiotic prophylaxis in cardiac surgery, part II: Antibiotic choice. Ann Thorac Surg 83:1569-1576, 2007
12. Clinical and Laboratory Standards Institute: Performance standards for antimicrobial disk susceptibility tests; approved standard (ed 10). Document M100-S20, Wayne, PA, 2010
13. Adrianzen Vargas MR, Danton MH, Javaid SM, et al: Pharmacokinetics of intravenous flucloxacillin and amoxicillin in neonatal and infant cardiopulmonary bypass surgery. Eur J Cardiothorac Surg 25:256-260, 2004 (Pubitemid 38125091)
14. Haessler D, Reverdy ME, Neidecker J, et al: Antibiotic prophylaxis with cefazolin and gentamicin in cardiac surgery for children less than ten kilograms. J Cardiothorac Vasc Anesth 17:221-225, 2003 (Pubitemid 36457479)
15. Davis PJ, Wilson AS, Siewers RD, et al: The effects of cardiopulmonary bypass on remifentanil kinetics in children undergoing atrial septal defect repair. Anesth Analg 89:904-908, 1999 (Pubitemid 29458463)
16. Pass SE, Miyagawa CI, Healy DP, et al: Serum concentrations of cefuroxime after continuous infusion in coronary bypass graft patients. Ann Pharmacother 35:409-413, 2001 (Pubitemid 32260205)
17. Holt DE, de Louvois J, Hurley R, et al: A high performance liquid chromatography system for the simultaneous assay of some antibiotics commonly found in combination in clinical samples. J Antimicrob Chemother 26:107-115, 1990 (Pubitemid 20263703)
18. D'Argenio DZ, Schumitzky A: ADAPT 5, User's Guide: Pharmacokinetic and Pharmacodynamic Systems Analysis Software. Los Angeles, CA: Biomedical Simulations Resource, University of Southern California; 2009
19. Bratzler DW: The Surgical Infection Prevention and Surgical Care Improvement Projects: Promises and pitfalls. Am Surg 72:1010-1016, 2006
20. Kearns GL, Abdel-Rahman SM, Alander SW, et al: Developmental pharmacology-Drug disposition, action, and therapy in infants and children. N Engl J Med 349:1157-1167, 2003 (Pubitemid 37122329)
21. Hiraoka H, Yamamoto K, Okano N, et al: Changes in drug plasma concentrations of an extensively bound and highly extracted drug, propofol, in response to altered plasma binding. Clin Pharmacol Ther 75:324-30, 2004 (Pubitemid 38471557)
22. Bitkover CY, Gardlund B: Mediastinitis after cardiovascular operations: A case-control study of risk factors. Ann Thorac Surg 65:36-40, 1998 (Pubitemid 28105867)
23. Caffarelli AD, Holden JP, Baron EJ, et al: Plasma cefazolin levels during cardiovascular surgery: Effects of cardiopulmonary bypass and profound hypothermic circulatory arrest. J Thorac Cardiovasc Surg 131:1338-1343, 2006 (Pubitemid 43776060)
24. Mets B: The pharmacokinetics of anesthetic drugs and adjuvants during cardiopulmonary bypass. Acta Anaesthesiol Scand 44:261-273, 2000
25. Buylaert WA, Herregods LL, Mortier EP, et al: Cardiopulmonary bypass and the pharmacokinetics of drugs. An update. Clin Pharmacokinet 17:10-26, 1989
26. Fellinger EK, Leavitt BJ, Hebert JC: Serum levels of prophylactic cefazolin during cardiopulmonary bypass surgery. Ann Thorac Surg 74:1187-1190, 2002 (Pubitemid 35176744)
27. Vuorisalo S, Pokela R, Syrjala H: Is single-dose antibiotic prophylaxis sufficient for coronary artery bypass surgery? An analysis of peri- and postoperative serum cefuroxime and vancomycin levels. J Hosp Infect 37:237-247, 1997 (Pubitemid 27501148)
28. Nascimento JW, Carmona MJ, Strabelli TM, et al: Systemic availability of prophylactic cefuroxime in patients submitted to coronary artery bypass grafting with cardiopulmonary bypass. J Hosp Infect 59:299-303, 2005 (Pubitemid 40331348)
29. Nascimento JW, Carmona MJ, Strabelli TM, et al: Perioperative cefuroxime pharmacokinetics in cardiac surgery. Clinics (Sao Paulo) 62:257-260, 2007
30. Maher KO, VanDerElzen K, Bove EL, et al: A retrospective review of three antibiotic prophylaxis regimens for pediatric cardiac surgical patients. Ann Thorac Surg 74:1195-1200, 2002 (Pubitemid 35176746)
31. Niederhauser U, Vogt M, Vogt P, et al: Cardiac surgery in a high-risk group of patients: is prolonged postoperative antibiotic prophylaxis effective? J Thorac Cardiovasc Surg 114:162-168, 1997
32. Allpress AL, Rosenthal GL, Goodrich KM, et al: Risk factors for surgical site infections after pediatric cardiovascular surgery. Pediatr Infect Dis J 23:231-234, 2004 (Pubitemid 38332648)
33. ASHP Therapeutic Guidelines on Antimicrobial Prophylaxis in Surgery. American Society of Health-System Pharmacists. Am J Health Syst Pharm 56:1839-1888, 1999
34. Gold B, Rodriguez WJ: Cefuroxime: mechanisms of action, antimicrobial activity, pharmacokinetics, clinical applications, adverse reactions and therapeutic indications. Pharmacotherapy 3:82-100, 1983
35. Craig WA: Basic pharmacodynamics of antibacterials with clinical applications to the use of beta-lactams, glycopeptides, and linezolid. Infect Dis Clin North Am 17:479-501, 2003